| 2023 | | Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy | 정성현 |
| 2022 | | BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis | 노진, 정성현, 최윤석 |
| 2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2023 | | Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation | 정성현, 최윤석 |
| 2023 | | Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404) | 정성현 |
| 2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
| 2020 | | Extranodal NK/T cell lymphoma | 정성현 |
| 2019 | | Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study | 정성현 |
| 2020 | | Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | 노진, 박준성, 정성현, 한재호 |
| 2023 | | Radioimmunotherapy with 131I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma | 정성현 |
| 2023 | | Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study | 정성현, 최윤석 |
| 2022 | | Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined with Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma | 노진, 박준성, 정성현, 최윤석 |
| 2023 | | The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma | 노진, 박준성, 정성현, 최윤석, 한재호 |
| 2022 | | Treatment of indolent lymphoma | 정성현 |
